The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel
Abstract
CONTEXT: New trial data and drug regimens that have become available in the last 2 years warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected adults in resource-rich settings. OBJECTIVE: To provide current recommendations for the treatment of adult HIV infection with ART and use of laboratory-monitoring tools. Guidelines include when to start therapy and with what drugs, monitoring for response and toxic effects, special considerations in therapy, and managing antiretroviral failure. DATA SOURCES, STUDY SELECTION, AND DATA EXTRACTION: Data that had been published or presented in abstract form at scientific conferences in the past 2 years were systematically searched and reviewed by an International Antiviral Society-USA panel. The panel reviewed available evidence and formed recommendations by full panel consensus. DATA SYNTHESIS: Treatment is recommended for all adults with HIV infection; the strength of the recommendation and the quality of the evidence increase with decreasing CD4 cell count and the presence of certain concurrent conditions. Recommended initial regimens include 2 nucleoside reverse transcriptase inhibitors (tenofovir/emtricitabine or abacavir/lamivudine) plus a nonnucleoside reverse transcriptase inhibitor (efavirenz), a ritonavir-boosted protease inhibitor (atazanavir or darunavir), or an integrase strand transfer inhibitor (raltegravir). Alternatives in each class are recommended for patients with or at risk of certain concurrent conditions. CD4 cell count and HIV-1 RNA level should be monitored, as should engagement in care, ART adherence, HIV drug resistance, and quality-of-care indicators. Reasons for regimen switching include virologic, immunologic, or clinical failure and drug toxicity or intolerance. Confirmed treatment failure should be addressed promptly and multiple factors considered. CONCLUSION: New recommendations for HIV patient care include offering ART to all patients regardless of CD4 cell count, changes in therapeutic options, and modifications in the timing and choice of ART in the setting of opportunistic illnesses such as cryptococcal disease and tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
Sexually transmitted disease surveillance.
Schofield, C. B. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-c · Cited by 1,869
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., Monforte, A. D., de Wolf, F., Reiss, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09411-4 · Cited by 1,525
Self-citationClass of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506816 · Cited by 2,798
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893
Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., Gill, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081355 · Cited by 1,417
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Self-citationHammer, S. M., Eron, J. J., Reiss, P., Schooley, R. T., Thompson, M. A., Walmsley, S., Cahn, P., Fischl, M. A., Gatell, J. M., Hirsch, M. S., et al. (2008) · JAMA · doi:10.1001/jama.300.5.555 · Cited by 1,026
Self-citationGlobal epidemiology of HIV among female sex workers: influence of structural determinants
Shannon, K., Strathdee, S. A., Goldenberg, S. M., Duff, P., Mwangi, P., Rusakova, M., Reza-Paul, S., Lau, J., Deering, K., Pickles, M. R., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60931-4 · Cited by 887
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
Walmsley, S. L., Antela, A., Clumeck, N., Duiculescu, D., Eberhard, A., Gutiérrez, F., Hocqueloux, L., Maggiolo, F., Sandkovsky, U., Granier, C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215541 · Cited by 876
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Maartens, G., Celum, C., & Lewin, S. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60164-1 · Cited by 830
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Self-citationDas, M., Chu, P. L., Santos, G.-M., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011068 · Cited by 771
Defective proviruses rapidly accumulate during acute HIV-1 infection
Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737
Self-citationCohen, M. S., Shaw, G. M., McMichael, A. J., & Haynes, B. F. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011874 · Cited by 660
Günthard, H. F., Saag, M. S., Benson, C. A., del Rio, C., Eron, J. J., Gallant, J. E., Hoy, J. F., Mugavero, M. J., Sax, P. E., Thompson, M. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.8900 · Cited by 656
Self-citationWorm, S. W., Sabin, C., Weber, R., Reiss, P., El‐Sadr, W., Dabis, F., De Wit, S., Law, M., Monforte, A. D., Friis‐Møller, N., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/649897 · Cited by 648
Self-citationThompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
Self-citationHuman Immunodeficiency Virus Transmission at Each Step of the Care Continuum in the United States
Skarbinski, J., Rosenberg, E., Paz-Bailey, G., Hall, H. I., Rose, C. E., Viall, A. H., Fagan, J. L., Lansky, A., & Mermin, J. H. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.8180 · Cited by 550
Raffi, F., Rachlis, A., Stellbrink, H.-J., Hardy, W. D., Torti, C., Orkin, C., Bloch, M., Podzamczer, D., Pokrovsky, V., Pulido, F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61853-4 · Cited by 548
Zhang, W., O’Brien, N., Forrest, J. I., Salters, K. A., Patterson, T. L., Montaner, J. S. G., Hogg, R. S., & Lima, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040793 · Cited by 542
The State of Engagement in HIV Care in the United States: From Cascade to Continuum to Control
Mugavero, M. J., Amico, K. R., Horn, T., & Thompson, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit420 · Cited by 508
Self-citationClotet, B., Feinberg, J., van Lunzen, J., Khuong-Josses, M.-A., Antinori, A., Dumitru, I., Pokrovskiy, V., Fehr, J., Ortiz, R., Saag, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60084-2 · Cited by 507
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 496
Self-citationGrinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., Wang, L., Ou, S.-S., Anderson, M., McCauley, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70692-3 · Cited by 494
Self-citationAntiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
Self-citationDinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 441
Webster, D. P., Klenerman, P., & Dusheiko, G. M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62401-6 · Cited by 439
2015 update of the drug resistance mutations in HIV-1
Wensing, A. M. J., Cálvez, V., Ceccherini‐Silberstein, F., Charpentier, C., Günthard, H. F., Jacobsen, D. M., Paredes, R., Shafer, R. W., & Richman, D. D. (2015) · PubMed · doi:10.5167/uzh-122257 · Cited by 415
Self-citationMolina, J.-M., Cahn, P., Grinsztejn, B., Lazzarin, A., Mills, A., Saag, M., Supparatpinyo, K., Walmsley, S., Crauwels, H., Rimsky, L. T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60936-7 · Cited by 405
Self-citationvan Sighem, A., Gras, L., Reiss, P., Brinkman, K., & de Wolf, F. (2010) · AIDS · doi:10.1097/qad.0b013e32833a3946 · Cited by 398
Self-citationZanoni, B. C., & Mayer, K. H. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0345 · Cited by 395
Pineda-Peña, A.-C., Faria, N. R., Imbrechts, S., Libin, P., Abecasis, A. B., Deforche, K., Gómez-López, A., Camacho, R. J., de Oliveira, T., & Vandamme, A.-M. (2013) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.04.032 · Cited by 383
Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti
Severe, P., Jean Juste, M. A., Ambroise, A., Eliacin, L., Marchand, C., Apollon, S., Edwards, A., Bang, H., Nicotera, J., Godfrey, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910370 · Cited by 377
Cohen, C. J., Andrade-Villanueva, J., Clotet, B., Fourie, J., Johnson, M. A., Ruxrungtham, K., Wu, H., Zorrilla, C., Crauwels, H., Rimsky, L. T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60983-5 · Cited by 374
Nano/Microfluidics for diagnosis of infectious diseases in developing countries
Lee, W. G., Kim, Y.-G., Chung, B. G., Demirci, U., & Khademhosseini, A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.016 · Cited by 357
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
Le, T., Wright, E. J., Smith, D. M., He, W., Catano, G., Okulicz, J. F., Young, J. A., Clark, R. A., Richman, D. D., Little, S. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1110187 · Cited by 355
Self-citationMontaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., Wood, E., Kerr, T., Shannon, K., Moore, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087872 · Cited by 354
A Review of the Toxicity of HIV Medications
Margolis, A. M., Heverling, H., Pham, P. A., & Stolbach, A. (2014) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0325-8 · Cited by 348
Hall, H. I., Frazier, E. L., Rhodes, P., Holtgrave, D. R., Furlow-Parmley, C., Tang, T., Gray, K. M., Cohen, S. M., Mermin, J., & Skarbinski, J. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6841 · Cited by 339
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Hoen, E. '., Berger, J., Calmy, A., & Moon, S. (2011) · Journal of the International AIDS Society · doi:10.1186/1758-2652-14-15 · Cited by 334
García-Sánchez, A., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2082145 · Cited by 331
HIV-1 Antiretroviral Resistance: Scientific Principles and Clinical Applications
Tang, M. W., & Shafer, R. W. (2012) · Drugs · doi:10.2165/11633630-000000000-00000 · Cited by 326
Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France
Roux, A., Canet, E., Valade, S., Gangneux-Robert, F., Hamane, S., Lafabrie, A., Maubon, D., Debourgogne, A., Le Gal, S., Dalle, F., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2009.131668 · Cited by 319
Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
Sax, P. E., Tierney, C., Collier, A. C., Fischl, M. A., Mollan, K., Peeples, L., Godfrey, C., Jahed, N. C., Myers, L., Katzenstein, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906768 · Cited by 313
Daar, E. S., Tierney, C., Fischl, M. A., Sax, P. E., Mollan, K., Budhathoki, C., Godfrey, C., Jahed, N. C., Myers, L., Katzenstein, D., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-7-201104050-00316 · Cited by 312
Self-citationLucas, G. M., Ross, M. J., Stock, P. G., Shlipak, M. G., Wyatt, C. M., Gupta, S. K., Atta, M. G., Wools-Kaloustian, K. K., Pham, P. A., Bruggeman, L. A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu617 · Cited by 310
HIV and aging: time for a new paradigm.
Justice, A. C. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0041-9 · Cited by 309
Study, T. S. H. C., Franceschi, S., Lise, M., Clifford, G. M., Rickenbach, M., Levi, F., Maspoli, M., Bouchardy, C., Dehler, S., Jundt, G., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605756 · Cited by 307
Ellis, R. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.76 · Cited by 306
Secondary immunodeficiencies, including HIV infection
Chinen, J., & Shearer, W. T. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.040 · Cited by 305
Laboratory testing for the diagnosis of HIV infection : updated recommendations
(U.S.), C. F. D. C. A. P., Bernard M., B., Association of Public Health Laboratorie, S. Michele, O., Laura G., W., Berry, B., Barbara G., W., Kelly E., W., & Michael A., P. (2014) · doi:10.15620/cdc.23447 · Cited by 305
HIV treatment as prevention and HPTN 052
Cohen, M. S., McCauley, M., & Gamble, T. R. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834f5cf2 · Cited by 301
Primary Care–Based Models for the Treatment of Opioid Use Disorder: A Scoping Review
Korthuis, P. T., McCarty, D., Weimer, M., Bougatsos, C., Blazina, I., Zakher, B., Grusing, S., Devine, B., & Chou, R. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2149 · Cited by 297
Labarga, P., Barreiro, P., Martin-Carbonero, L., Rodriguez-Novoa, S., Solera, C., Medrano, J., Rivas, P., Albalater, M., Blanco, F., Moreno, V., et al. (2009) · AIDS · doi:10.1097/qad.0b013e3283262a64 · Cited by 294
HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention
Blair, W. S., Pickford, C., Irving, S. L., Brown, D. G., Anderson, M., Bazin, R., Cao, J., Ciaramella, G., Isaacson, J., Jackson, L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001220 · Cited by 291
Hamers, R. L., Wallis, C. L., Kityo, C., Siwale, M., Mandaliya, K., Conradie, F., Botes, M. E., Wellington, M., Osibogun, A., Sigaloff, K. C. E., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70149-9 · Cited by 287
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
Honeycutt, J. B., Thayer, W. O., Baker, C. E., Ribeiro, R. M., Lada, S. M., Cao, Y., Cleary, R. A., Hudgens, M. G., Richman, D. D., & Garcia, J. V. (2017) · Nature Medicine · doi:10.1038/nm.4319 · Cited by 281
Self-citationAdherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., & Peterson, G. M. (2016) · Medicine · doi:10.1097/md.0000000000003361 · Cited by 277
for the Canadian Observation Cohort (CANOC) Collaboration, Tanner, Z., Lachowsky, N., Ding, E., Samji, H., Hull, M., Cescon, A., Patterson, S., Chia, J., Leslie, A., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1926-z · Cited by 270
Collateral sensitivity of antibiotic-resistant microbes
Pál, C., Papp, B., & Lázár, V. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.02.009 · Cited by 270
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit757 · Cited by 268
Self-citationChe, C.-T., Wang, Z., Chow, M., & Lam, C. (2013) · Molecules · doi:10.3390/molecules18055125 · Cited by 265
Excess Cancers Among HIV-Infected People in the United States
Robbins, H. A., Pfeiffer, R. M., Shiels, M. S., Li, J., Hall, H. I., & Engels, E. A. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju503 · Cited by 262
Peluso, M. J., Ferretti, F., Peterson, J., Lee, E., Fuchs, D., Boschini, A., Gisslén, M., Angoff, N., Price, R. W., Cinque, P., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328355e6b2 · Cited by 252
Freeman, R., Gwadz, M. V., Silverman, E., Kutnick, A., Leonard, N. R., Ritchie, A. S., Reed, J., & Martinez, B. Y. (2017) · International Journal for Equity in Health · doi:10.1186/s12939-017-0549-3 · Cited by 184
“These advances, in turn, have allowed persons living with HIV (PLWH) to experience a higher quality of life and a longer lifespan than in the earlier phases of the HIV pandemic [2, 3].”
BackgroundLosina, E., Schackman, B. R., Sadownik, S. N., Gebo, K. A., Walensky, R. P., Chiosi, J. J., Weinstein, M. C., Hicks, P. L., Aaronson, W. H., Moore, R. D., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/644772 · Cited by 180
Mbuagbaw, L., van der Kop, M. L., Lester, R. T., Thirumurthy, H., Pop-Eleches, C., Ye, C., Smieja, M., Dolovich, L., Mills, E. J., & Thabane, L. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003950 · Cited by 147
Hukezalie, K. R., Thumati, N. R., Côté, H. C. F., & Wong, J. M. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047505 · Cited by 84
The feasibility of lung transplantation in HIV-seropositive patients
Kern, R. M., Seethamraju, H., Blanc, P. D., Sinha, N., Loebe, M., Golden, J., Kukreja, J., Scheinin, S., Hays, S., Kleinhenz, M. E., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201402-083oc · Cited by 58
Pollack, H. A., Pereyra, M., Parish, C. L., Abel, S., Messinger, S., Singer, R., Kunzel, C., Greenberg, B., Gerbert, B., Glick, M., et al. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301700 · Cited by 53
Cardiovascular disease risk in an aging HIV population: not just a question of biology
So-Armah, K., & Freiberg, M. S. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000065 · Cited by 45
The Race against Protease Activation Defines the Role of ESCRTs in HIV Budding
Bendjennat, M., & Saffarian, S. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005657 · Cited by 45
The Critical Need for Alternative Antiretroviral Formulations, and Obstacles to Their Development
Swindells, S., Flexner, C., Fletcher, C. V., & Jacobson, J. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir370 · Cited by 42
HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes
Xiao, T., Frey, G., Fu, Q., Lavine, C. L., Scott, D. A., Seaman, M. S., Chou, J. J., & Chen, B. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0496-y · Cited by 38
“The latest cART regimen uses several classes of antiviral therapeutics, including nucleoside/nucleotide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, coreceptor inhibitors and integrase inhibitors 4,5 .”
Trends in Encephalitis-Associated Deaths in the United States, 1999-2008
Tack, D. M., Holman, R. C., Folkema, A. M., Mehal, J. M., Blanton, J. D., & Sejvar, J. J. (2014) · Neuroepidemiology · doi:10.1159/000362688 · Cited by 36
Healthcare Costs Associated with Antiretroviral Adherence Among Medicaid Patients
Pruitt, Z., Robst, J., Langland-Orban, B., & Brooks, R. G. (2015) · Applied Health Economics and Health Policy · doi:10.1007/s40258-014-0138-1 · Cited by 11
Metadata
- Authors
- Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., Richman, D. D., Rizzardini, G., Thomas, D. L., Jacobsen, D. M., & Volberding, P. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-07-25
- Volume
- 308
- Issue
- 4
- Pages
- 387-25
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2148750104
- Cited by
- 2,469
- References
- 165
- FWCI
- 232.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.